Literature DB >> 11390031

Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity.

A Propato1, E Schiaffella, E Vicenzi, V Francavilla, L Baloni, M Paroli, L Finocchi, N Tanigaki, S Ghezzi, R Ferrara, R Chesnut, B Livingston, A Sette, R Paganelli, F Aiuti, G Poli, V Barnaba.   

Abstract

Long-term non-progressors (LTNP) represent a minority of human immunodeficiency virus (HIV) infected individuals characterized by stable or even increasing CD4+ T-cell count and by stronger immune responses against HIV than progressors. In this study, HIV-specific effector CD8+ T cells, as detected by both a sensitive ex vivo enzyme-linked immunospot (ELISPOT) assay and specific major histocompatibility complex (MHC) peptide tetramers, were at a low frequency in the peripheral blood of LTNP, and recognized a lower number of HIV peptides than their memory resting cell counterparts. Both factors may account for the lack of complete HIV clearance by LTNP, who could control the viral spread, and displayed a higher magnitude of cytotoxic T lymphocyte (CTL) responses than progressors. By combining cell purification and ELISPOT assays this study demonstrates that both effector and memory resting cells were confined to a CD8+ population with memory CD45RO+ phenotype, with the former being CD28- and the latter CD28+. Longitudinal studies highlighted a relatively stable HIV-specific effector repertoire, viremia, and CD4+ T-cell counts, which were all correlated with maintenance of nonprogressor status. In conclusion, the analysis of HIV-specific cellular responses in these individuals may help define clear correlates of protective immunity in HIV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390031     DOI: 10.1016/s0198-8859(01)00245-2

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  18 in total

1.  Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 protease.

Authors:  Sandra M Mueller; Birgit Schaetz; Kathrin Eismann; Silke Bergmann; Michael Bauerle; Matthias Schmitt-Haendle; Hauke Walter; Barbara Schmidt; Klaus Korn; Heinrich Sticht; Bernd Spriewald; Ellen G Harrer; Thomas Harrer
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

Review 2.  Current advances and challenges in HIV-1 vaccines.

Authors:  Isaac R Rodriguez-Chavez; Mary Allen; Edgar L Hill; Rebecca L Sheets; Michael Pensiero; James A Bradac; M Patricia D'Souza
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

3.  Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression.

Authors:  Claudia Pastori; Barbara Weiser; Claudia Barassi; Caterina Uberti-Foppa; Silvia Ghezzi; Renato Longhi; Giliola Calori; Harold Burger; Kimdar Kemal; Guido Poli; Adriano Lazzarin; Lucia Lopalco
Journal:  Blood       Date:  2006-03-07       Impact factor: 22.113

4.  Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8+ T cells in infected children correlate positively with plasma viral load.

Authors:  Florence Buseyne; Daniel Scott-Algara; Françoise Porrot; Béatrice Corre; Nassima Bellal; Marianne Burgard; Christine Rouzioux; Stéphane Blanche; Yves Rivière
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Induction of primary anti-HIV CD4 and CD8 T cell responses by dendritic cells transduced with self-inactivating lentiviral vectors.

Authors:  Xiaochuan Chen; Bei Wang; Lung-Ji Chang
Journal:  Cell Immunol       Date:  2006-12-22       Impact factor: 4.868

6.  T cell receptor usage in patients with non-progressing HIV infection.

Authors:  M D Bodman-Smith; I Williams; R Johnstone; A Boylston; P M Lydyard; A Zumla
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

7.  Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among HIV-1 infected individuals before and after antiretroviral therapy.

Authors:  Carmem Beatriz Wagner Giacoia-Gripp; Ivan Neves; Maria Clara Galhardo; Mariza Gonçalves Morgado
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

Review 8.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Cellular Immune Response Induced by DNA Immunization of Mice with Drug Resistant Integrases of HIV-1 Clade A Offers Partial Protection against Growth and Metastatic Activity of Integrase-Expressing Adenocarcinoma Cells.

Authors:  Maria Isaguliants; Olga Krotova; Stefan Petkov; Juris Jansons; Ekaterina Bayurova; Dzeina Mezale; Ilze Fridrihsone; Athina Kilpelainen; Philip Podschwadt; Yulia Agapkina; Olga Smirnova; Linda Kostic; Mina Saleem; Oleg Latyshev; Olesja Eliseeva; Anastasia Malkova; Tatiana Gorodnicheva; Britta Wahren; Ilya Gordeychuk; Elizaveta Starodubova; Anastasia Latanova
Journal:  Microorganisms       Date:  2021-06-04

10.  Cellular gene expression profiles in rhesus macaques challenged mucosally with a pathogenic R5 tropic simian human immunodeficiency virus isolate.

Authors:  Hye-kyung Chung; Cynthia A Pise-Masison; Michael F Radonovich; John Brady; Jae K Lee; Soo-Young Cheon; Phillip Markham; Anthony Cristillo; Ranajit Pal
Journal:  Viral Immunol       Date:  2008-12       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.